Sign Up to like & get
recommendations!
0
Published in 2020 at "Nano letters"
DOI: 10.1021/acs.nanolett.9b05094
Abstract: Small-molecule therapeutics demonstrate sub-optimal pharmacokinetics and bioavailability due to their hydrophobicity and size. One way to overcome these limitations-and improve their efficacy-is to use "stealth" macromolecular carriers that evade uptake by the reticuloendothelial system. Although…
read more here.
Keywords:
therapeutic window;
stealth;
window abraxane;
wider therapeutic ... See more keywords